Male sex accelerates cognitive decline in GBA1 Parkinson’s disease
Abstract We evaluated 128 GBA and 432 nonGBA Parkinson’s disease (PD) subjects available from Parkinson’s Progression Markers Initiative. Baseline clinical features and dopaminergic activity were assessed, together with clinical follow-up (6.87 ± 3.2 years). Survival analyses assessed the independen...
Saved in:
| Main Authors: | Silvia Paola Caminiti, Micol Avenali, Alice Galli, Rachele Malito, Giada Cuconato, Caterina Galandra, Rosaria Calabrese, Andrea Pilotto, Alessandro Padovani, Fabio Blandini, Daniela Perani, Cristina Tassorelli, Enza Maria Valente |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | npj Parkinson's Disease |
| Online Access: | https://doi.org/10.1038/s41531-025-00883-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants
by: Stefanie Lerche, et al.
Published: (2024-10-01) -
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol
by: Matteo Gastaldi, et al.
Published: (2023-10-01) -
GBA mutations and Parkinson's disease in Brazil
by: Carlos R. M. Rieder -
Dual-Task Performance in GBA Parkinson’s Disease
by: Karin Srulijes, et al.
Published: (2017-01-01) -
Is Gauchian genotyping of GBA1 variants reliable?
by: Nahid Tayebi, et al.
Published: (2025-05-01)